Article

Improve your bottom line by selling top-line eyewear

"The best way to improve your bottom line is to improve your top lines-sell luxury, branded eyewear," said Sam Buemi, regional manager, Safilo USA. "If you carry fashion eyewear and your staff learns to sell fashion eyewear, your bottom line will improve."

"The best way to improve your bottom line is to improve your top lines-sell luxury, branded eyewear," said Sam Buemi, regional manager, Safilo USA. "If you carry fashion eyewear and your staff learns to sell fashion eyewear, your bottom line will improve."

Buemi gave that marketing advice and more during his symposium "The Power of Fashion Branding: Maximizing Profits in Your Dispensary," presented at the Ophthalmology Times/American Association of Dispensing Ophthalmologists Dispensing Solutions Pavilion.

He went on to explain why selling fashion eyewear is key to increasing per patient sales.

"The average patient comes back to your optical dispensary between 24 and 48 months," Buemi said. "When you sell fashion eyewear and branded eyewear, you shorten the distance between patients coming into your office.

"They're not buying a medical device, they're buying fashion," he said.

Buemi further described what brand name eyewear means to a dispensary:

  • Instant recognition and prestige.


  • Sends a message of quality.


  • Sends a message of value.


  • Conveys an image.


  • Instills trust.


  • Creates a fashion atmosphere.


  • Generates more top line profits to the practice.

Buemi will again present the program today, Nov. 14, at 10:45 a.m. in the Dispensing Solutions Pavilion, Booth 2272, Sands Expo and Convention Center.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.